Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-07FDA Approved: RANITIDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Rising Pharma Holdings, Inc., indicating an approved change to the p…
-
FDA approval · 2019-07-02FDA Approved: MISOPROSTOL — Original Application (AvPAK)
FDA approved a generic version of misoprostol under AvPAK's original ANDA, for prevention of NSAID-induced gastric ulcers.
-
FDA approval · 2019-07-01FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lansoprazole from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA process.
-
FDA approval · 2019-05-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original generic application for esomeprazole magnesium, authorizing its use as a proton pump inhibitor. The pro…
-
FDA approval · 2019-05-10FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd., approving the generic product update.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-03FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for omeprazole from Aurobindo Pharma Limited under ANDA203270.
-
FDA approval · 2019-04-09FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
FDA approval · 2019-04-04FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) filed by Haleon US Holdings LLC.
-
FDA approval · 2019-03-26FDA Approved: TAGAMET — Supplemental Application (Prestige Brands Holdings, Inc.)
FDA approved a supplemental application for Tagamet (cimetidine) from Prestige Brands Holdings, Inc., resulting in an updated product labeli…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT [Phase 2, Phase 3]
A randomized trial update on a cytoprotective agent for preventing gastric and duodenal ulcers induced by antiplatelet therapy, with Phase 2…
-
FDA approval · 2019-02-07FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Lannett Company's generic rabeprazole sodium product.
-
CLINICAL_TRIALS research · 2019-02-07Clinical Trial Update: Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
This clinical trial update outlines the post-therapy sample collection protocol for subjects with Helicobacter pylori infection and gastric …
-
FDA approval · 2019-02-01FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for rabeprazole sodium (generic) submitted by Aurobindo Pharma Limited. This confirms an approve…
-
FDA approval · 2019-01-31FDA Approved: RANITIDINE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original ANDA for ranitidine from Rising Pharma Holdings, Inc., enabling the marketing of a generic ranitidine product.
-
FDA approval · 2019-01-18FDA Approved: LANSOPRAZOLE — Original Application (Medcore LLC)
The FDA approved Lansoprazole as an original generic application (ANDA) from Medcore LLC, making a generic version available.
-
FDA approval · 2018-11-30FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Rabeprazole SODIUM from Torrent Pharmaceuticals Limited.
-
FDA approval · 2018-11-27FDA Approved: LANSOPRAZOLE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original Abbreviated New Drug Application for lansoprazole from Zydus Pharmaceuticals USA Inc., enabling a generic version …
-
FDA approval · 2018-11-05FDA Approved: OMEPRAZOLE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' original ANDA for a generic omeprazole product. Omeprazole is a proton pump inhibitor indicated for gas…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium [Phase 4]
A phase 4 clinical trial evaluating the combination of E0671 and rabeprazole for gastric ulcers has been completed.
-
FDA approval · 2018-10-05FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination of bismuth subitrate potassium, metronidazole, and tetracycline hydrochloride (H…
-
FDA approval · 2018-09-27FDA Approved: RANITIDINE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s Original Application for ranitidine, a generic H2 blocker, with label indications including treatment …
-
FDA approval · 2018-08-20FDA Approved: RANITIDINE — Original Application (Granules India Ltd)
FDA approved Granules India Ltd's original application for ranitidine (generic). The product is intended for conditions such as duodenal and…
-
FDA approval · 2018-07-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Esomeprazole Magnesium. This approval authorizes the marketi…
-
FDA approval · 2018-07-20FDA Approved: OMEPRAZOLE — Original Application (INNOVUS PHARMACEUTICALS, INC.)
FDA approved a generic version of omeprazole (omeprazole and omeprazole magnesium) under ANDA210593 from Innovus Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
This completed trial evaluated the efficacy of a low-dose proton pump inhibitor for the treatment of bleeding ulcers, including marginal ulc…